These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21537664)

  • 41. Pulmonary arterial hypertension occurrence after liver transplant in systemic sclerosis: a report of 2 cases sustainably treated by sildenafil.
    Koumakis E; Wipff J; Kahan A; Allanore Y
    Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S53-4. PubMed ID: 20576215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease.
    Corte TJ; Gatzoulis MA; Parfitt L; Harries C; Wells AU; Wort SJ
    Respirology; 2010 Nov; 15(8):1226-32. PubMed ID: 20920139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of pulmonary arterial hypertension on idiopathic pulmonary fibrosis.
    Fell CD; Martinez FJ
    Chest; 2007 Mar; 131(3):641-3. PubMed ID: 17356072
    [No Abstract]   [Full Text] [Related]  

  • 44. [Sildenafil in chronic cutaneous ulcers refractory to other treatments].
    Castellanos Gonzalez M; Maroñas Jiménez L; Sanz Bueno J; Postigo C
    Med Clin (Barc); 2013 Apr; 140(7):332-3. PubMed ID: 23177303
    [No Abstract]   [Full Text] [Related]  

  • 45. Should right ventricle dilatation during exercise have clinical implications in patients with chronic thromboembolic pulmonary hypertension? Case report.
    Cotrim C; Loureiro MJ; Miranda R; Almeida S; Almeida AR; Simões O; Cordeiro P; Carrageta M
    Cardiovasc Ultrasound; 2007 Dec; 5():50. PubMed ID: 18162132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral sildenafil for persistent pulmonary hypertension early after congenital cardiac surgery in children.
    Nemoto S; Sasaki T; Ozawa H; Katsumata T; Kishi K; Okumura K; Mori Y; Umegaki O
    Eur J Cardiothorac Surg; 2010 Jul; 38(1):71-7. PubMed ID: 20206543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sildenafil as a pulmonary vasodilator after repair of congenital heart disease.
    Kovacikova L; Zahorec M; Nosal M
    Bratisl Lek Listy; 2007; 108(10-11):453-4. PubMed ID: 18306725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversible pre-capillary pulmonary hypertension due to dasatinib.
    Buchelli Ramirez HL; Álvarez Álvarez CM; Rodríguez Reguero JJ; García Clemente MM; Casan Clarà P
    Respir Care; 2014 May; 59(5):e77-80. PubMed ID: 24149673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Invited commentary.
    van der Starre P
    Ann Thorac Surg; 2011 Dec; 92(6):2176. PubMed ID: 22115227
    [No Abstract]   [Full Text] [Related]  

  • 50. [Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension].
    Montani D; Humbert M
    Rev Mal Respir; 2010 Feb; 27(2):103-5. PubMed ID: 20206056
    [No Abstract]   [Full Text] [Related]  

  • 51. Inoperable chronic thromboembolic pulmonary hypertension: treatable with medical therapy.
    Hill NS; Preston IR; Roberts KE
    Chest; 2008 Aug; 134(2):221-223. PubMed ID: 18682450
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension.
    Chau EM; Fan KY; Chow WH
    Int J Cardiol; 2007 Sep; 120(3):301-5. PubMed ID: 17174418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Optimization of the use of phosphodiesterase-5 inhibitors].
    Pushkar' DIu; Segal AS
    Urologiia; 2012; (4):79-80, 82. PubMed ID: 23116030
    [No Abstract]   [Full Text] [Related]  

  • 54. [Primary arterial pulmonary hypertension and sildenafil: a case report from Dakar].
    Bouldouyre M; Dia D; Ba FK; Diop IB; Debonne JM
    Dakar Med; 2006; 51(2):78-80. PubMed ID: 17632981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
    Ghofrani HA; Grimminger F
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S311-4. PubMed ID: 17139594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Not just for men.
    Prat NM; Sánchez-Dalmau BF; Foroozan R
    Surv Ophthalmol; 2011; 56(2):173-7. PubMed ID: 21035828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
    Chapman TH; Wilde M; Sheth A; Madden BP
    Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sildenafil for noncompaction cardiomyopathy treatment in a child: case report.
    Redondo AC; Fuenmayor G; Shiraishi KS; Fontes SR; Elias PF; Souza R; Jatene IB
    Arq Bras Cardiol; 2014 Mar; 102(3):e27-30. PubMed ID: 24714790
    [No Abstract]   [Full Text] [Related]  

  • 59. Pulmonary artery hypertension in heart transplant recipients: how much is too much?
    De Santo LS; Romano G; Maiello C; Buonocore M; Cefarelli M; Galdieri N; Nappi G; Amarelli C
    Eur J Cardiothorac Surg; 2012 Nov; 42(5):864-9; discussion 869-70. PubMed ID: 22402452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained benefit of tadalafil in patients with pulmonary arterial hypertension with prior response to sildenafil: a case series of 12 patients.
    Tay EL; Geok-Mui MK; Poh-Hoon MC; Yip J
    Int J Cardiol; 2008 Apr; 125(3):416-7. PubMed ID: 17407795
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.